294860-58-5 Usage
General Description
Methyl 2-(5-bromo-2-methoxyphenyl)acetate is a chemically synthesized compound which belongs to the category of organic compounds specifically known as benzene and substituted derivatives. Its molecular formula is C10H11BrO3. Due to the presence of a bromine atom, this molecule is relatively heavier. The compound is mostly in liquid form and is well-known for its prevalence of induction in crystal formation, due to its specific chemical structure. It has a vital role in various scientific research for its unique properties. Despite these benefits, contact with the compound should be avoided as it may cause skin and eye irritation. Further research is recommended for advanced applications and safe handling of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 294860-58-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,4,8,6 and 0 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 294860-58:
(8*2)+(7*9)+(6*4)+(5*8)+(4*6)+(3*0)+(2*5)+(1*8)=185
185 % 10 = 5
So 294860-58-5 is a valid CAS Registry Number.
294860-58-5Relevant articles and documents
TRIAZOLONE COMPOUNDS AND USES THEREOF
-
Paragraph 00106, (2014/07/08)
The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leuke
ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
-
Page/Page column 119, (2009/10/21)
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such a
SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS
-
Page/Page column 35-36, (2008/06/13)
The invention provides compounds (Ia), (Ib) and (Ic), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated
